Crossref
journal-article
Elsevier BV
Cancer Treatment Reviews (78)
References
44
Referenced
42
10.1007/BF01052722
/ J Neurooncol / The basis of current treatment recommendations for malignant glioma by Fine (1994)10.1016/0360-3016(90)90096-3
/ Int J Radiat Oncol Biol Phys / Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report by Levin (1990)10.1016/S0959-8049(98)00146-4
/ Eur J Cancer / A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas by Gundersen (1998)10.1212/WNL.51.5.1250
/ Neurology / The functional role of tumor suppressor genes in gliomas by Fueyo (1998)10.1002/(SICI)1097-0215(19960621)69:3<236::AID-IJC14>3.0.CO;2-5
/ Int J Cancer / Association of p53 gene mutation with decreased chemosensitivity in human malignant glioma by Iwadate (1996)10.1073/pnas.95.24.14453
/ Proc Natl Acad Sci USA / The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21 (BAX) by Shu (1998)10.1016/S0360-3016(98)00393-9
/ Int J Radiat Oncol Biol Phys / p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors by Haas-Kogan (1999){'key': '10.1053/ctrv.1999.0145_RF8', 'first-page': '332', 'article-title': 'p53 status has no prognostic significance in glioblastomas treated with radiotherapy', 'volume': '16', 'author': 'Baxendine-Jones', 'year': '1997', 'journal-title': 'Clin Neuropathol'}
/ Clin Neuropathol / p53 status has no prognostic significance in glioblastomas treated with radiotherapy by Baxendine-Jones (1997){'key': '10.1053/ctrv.1999.0145_RF9', 'first-page': '1793', 'article-title': 'Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations', 'volume': '58', 'author': 'Tada', 'year': '1998', 'journal-title': 'Cancer Res'}
/ Cancer Res / Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations by Tada (1998){'key': '10.1053/ctrv.1999.0145_RF10', 'first-page': '797', 'article-title': 'Structures and functions of the tumor suppressor p53', 'volume': '45', 'author': 'Milner', 'year': '1997', 'journal-title': 'Pathol Biol'}
/ Pathol Biol / Structures and functions of the tumor suppressor p53 by Milner (1997)10.1046/j.1365-2168.1998.00910.x
/ Br J Surg / The p53 tumour suppressor gene by Steele (1998)10.1038/sj.onc.1202576
/ Oncogene / Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress by Amundson (1998)10.1038/sj.cgt.7700009
/ Cancer Gene Ther / Combined radiation and p53 gene therapy of malignant glioma cells by Badie (1999)10.1200/JCO.1998.16.9.3158
/ J Clin Oncol / Tumor suppressor p53: implications for tumor development and prognosis by Kirsch (1998)10.1093/jnci/85.9.704
/ J Natl Cancer Inst / Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials by Curran (1993)10.1007/BF00167068
/ J Neurooncol (1990)10.1016/0360-3016(93)90203-8
/ Int J Radiat Oncol Biol Phys / Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive RTOG clinical trials by Simpson (1993)10.1097/00006123-199804000-00021
/ Neurosurgery / Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy by Hilton (1998)10.1002/gcc.2870100211
/ Genes Chromosomes Cancer / TP53 alterations and clinical outcome in low grade astrocytomas by Kraus (1994)10.1111/j.1750-3639.1998.tb00191.x
/ Brain Pathol / Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, mdm2 or bcl-2 genes by Newcomb (1998)10.1046/j.1365-2990.1998.00137.x
/ Neuropath Appl Neurobiol / Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas by Bouvier-Labit (1998){'key': '10.1053/ctrv.1999.0145_RF22', 'first-page': '1617', 'article-title': 'Prognostic significance of p53 immunoreactivity in patients with glioma', 'volume': '1', 'author': 'Kyritsis', 'year': '1995', 'journal-title': 'Clin Cancer Res'}
/ Clin Cancer Res / Prognostic significance of p53 immunoreactivity in patients with glioma by Kyritsis (1995)10.1016/S0344-0338(98)80085-X
/ Pathol Res Pract / p53 protein expression in grade II astrocytomas: immunohistochemical study of 100 cases with long-term follow-up by Vital (1998)10.1038/bjc.1994.107
/ Br J Cancer / p53 protein in low-grade astrocytomas: a study with long-term follow-up by Iuzzolino (1994)10.1080/02688699844817
/ Br J Neurosurg / Prognostic factors in supratentorial WHO grade Ii astrocytoma in adults by Shinoda (1998)10.1080/02688699550041476
/ Br J Neurosurg / p53 immunoreactivity in astrocytomas and its relationship to survival by AI-Sarraj (1995)10.1023/A:1005727902387
/ J Neuro Oncol / p53 protein in pediatric malignant astrocytomas: a study of 21 patients by Bhattacharjee (1997)10.1227/00006123-199411000-00005
/ Neurosurgery / Prognostic implications of p53 overexpression in supratentorial astrocytic tumors by Chozick (1994)10.3171/jns.1997.86.1.0121
/ J Neurosurg / Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value by Cunningham (1997){'key': '10.1053/ctrv.1999.0145_RF30', 'first-page': '67', 'article-title': 'Accumulation of nuclear p53 protein and prognosis of astrocytomas in childhood and adolescence', 'volume': '15', 'author': 'Drach', 'year': '1996', 'journal-title': 'Clin Neuropathol'}
/ Clin Neuropathol / Accumulation of nuclear p53 protein and prognosis of astrocytomas in childhood and adolescence by Drach (1996){'key': '10.1053/ctrv.1999.0145_RF31', 'first-page': '299', 'article-title': 'Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival', 'volume': '44', 'author': 'Ehrmann', 'year': '1997', 'journal-title': 'Neoplasma'}
/ Neoplasma / Prognostic factors in astrocytomas: relationship of p53, MDM-2, BCL-2 and PCNA immunohistochemical expression to tumor grade and overall patient survival by Ehrmann (1997)10.1136/jnnp.59.4.413
/ J Neurol Neurosurg Psy / Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies by Ellison (1995){'key': '10.1053/ctrv.1999.0145_RF33', 'first-page': '607', 'article-title': 'Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erb b-2 immunostaining', 'volume': '14', 'author': 'Hwang', 'year': '1998', 'journal-title': 'Kaohsiung J Med Sci'}
/ Kaohsiung J Med Sci / Prognostic evaluation in supratentorial astrocytic tumors using p53, epidermal growth factor receptor, c-erb b-2 immunostaining by Hwang (1998)10.1097/00019606-199412000-00005
/ Diagn Mol Pathol / Prognostic significance of p53 immunoreactivity in adult patients with supratentorial fibrillary astrocytic neoplasms by Montine (1994)10.1007/s004010050721
/ Acta Neuropathol / Bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status by Newcomb (1997)10.1023/A:1005841520514
/ J Neuro Oncol / Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumor-suppressor gene products on survival by Rainov (1997){'key': '10.1053/ctrv.1999.0145_RF37', 'first-page': '547', 'article-title': 'Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation', 'volume': '15', 'author': 'James', 'year': '1999', 'journal-title': 'Int J Oncol'}
/ Int J Oncol / Tumor suppressor gene alterations in malignant gliomas: histopathological associations and prognostic evaluation by James (1999)10.1038/bjc.1997.216
/ Br J Cancer / MDM 2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor by Korkolopoulou (1997)10.1007/s004010050848
/ Acta Neuropathol / Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival by Korkolopoulou (1998){'key': '10.1053/ctrv.1999.0145_RF40', 'first-page': '304', 'article-title': 'The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood', 'volume': '57', 'author': 'Pollack', 'year': '1997', 'journal-title': 'Cancer Res'}
/ Cancer Res / The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood by Pollack (1997)10.1227/00006123-199508000-00009
/ Neurosurgery / Aberrant p53 expression does not correlate with the prognosis in anaplastic astrocytoma by Danks (1995)10.1017/S0317167100032984
/ Can J Neurol Sci / Prognostic factors in oligodendroglioma by Schiffer (1997)10.1002/(SICI)1097-0142(19990815)86:4<672::AID-CNCR17>3.0.CO;2-G
/ Cancer / Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors by Perry (1999)10.1200/JCO.1997.15.12.3423
/ J Clin Oncol / Chemosensitive gliomas in adults: which ones and why? by Mason (1997)
Dates
Type | When |
---|---|
Created | 22 years, 11 months ago (Sept. 19, 2002, 9:54 a.m.) |
Deposited | 6 years, 4 months ago (April 11, 2019, 9:54 p.m.) |
Indexed | 2 months, 2 weeks ago (June 11, 2025, 5:28 a.m.) |
Issued | 25 years, 6 months ago (Feb. 1, 2000) |
Published | 25 years, 6 months ago (Feb. 1, 2000) |
Published Print | 25 years, 6 months ago (Feb. 1, 2000) |
@article{Nieder_2000, title={The challenge of p53 as prognostic and predictive factor in gliomas}, volume={26}, ISSN={0305-7372}, url={http://dx.doi.org/10.1053/ctrv.1999.0145}, DOI={10.1053/ctrv.1999.0145}, number={1}, journal={Cancer Treatment Reviews}, publisher={Elsevier BV}, author={Nieder, C. and Petersen, S. and Petersen, C. and Thames, H.D.}, year={2000}, month=feb, pages={67–73} }